Matches in Wikidata for { <http://www.wikidata.org/entity/Q104684902> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q104684902 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 28ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q104684902 description "article scientifique publié en 2020" @default.
- Q104684902 description "artículu científicu espublizáu n'avientu de 2020" @default.
- Q104684902 description "scientific article published on 28 December 2020" @default.
- Q104684902 description "wetenschappelijk artikel" @default.
- Q104684902 description "наукова стаття, опублікована 28 грудня 2020" @default.
- Q104684902 name "Long acting polycaprolactone based parenteral formulation of aripiprazole targeting behavioral and biochemical deficit in schizophrenia" @default.
- Q104684902 name "Long acting polycaprolactone based parenteral formulation of aripiprazole targeting behavioral and biochemical deficit in schizophrenia" @default.
- Q104684902 name "Long acting polycaprolactone based parenteral formulation of aripiprazole targeting behavioral and biochemical deficit in schizophrenia" @default.
- Q104684902 type Item @default.
- Q104684902 label "Long acting polycaprolactone based parenteral formulation of aripiprazole targeting behavioral and biochemical deficit in schizophrenia" @default.
- Q104684902 label "Long acting polycaprolactone based parenteral formulation of aripiprazole targeting behavioral and biochemical deficit in schizophrenia" @default.
- Q104684902 label "Long acting polycaprolactone based parenteral formulation of aripiprazole targeting behavioral and biochemical deficit in schizophrenia" @default.
- Q104684902 prefLabel "Long acting polycaprolactone based parenteral formulation of aripiprazole targeting behavioral and biochemical deficit in schizophrenia" @default.
- Q104684902 prefLabel "Long acting polycaprolactone based parenteral formulation of aripiprazole targeting behavioral and biochemical deficit in schizophrenia" @default.
- Q104684902 prefLabel "Long acting polycaprolactone based parenteral formulation of aripiprazole targeting behavioral and biochemical deficit in schizophrenia" @default.
- Q104684902 P1433 Q104684902-DAFD4C56-DB0E-4EBE-98EE-FC3DE9EE89E0 @default.
- Q104684902 P1476 Q104684902-FD814922-9274-4546-B7F7-DF36348B42AE @default.
- Q104684902 P2093 Q104684902-952E24DD-7B62-47E8-8988-865F680EB725 @default.
- Q104684902 P2093 Q104684902-C1AE4CE4-3336-4F9B-A97F-6CD8D42BAF11 @default.
- Q104684902 P31 Q104684902-7720D1B2-CABB-4247-9998-7C20BBF8E4F8 @default.
- Q104684902 P356 Q104684902-E90C5A87-C416-4999-97DB-83E350924D3E @default.
- Q104684902 P577 Q104684902-1398C85B-C693-4DC5-9185-50F681807331 @default.
- Q104684902 P698 Q104684902-B5DFD082-F466-47B5-9DE1-C0E6FE851B71 @default.
- Q104684902 P921 Q104684902-2482FE42-7163-4BEF-9EC5-5C1FF3457A8D @default.
- Q104684902 P356 J.XPHS.2020.12.028 @default.
- Q104684902 P698 33383057 @default.
- Q104684902 P1433 Q3186933 @default.
- Q104684902 P1476 "Long acting polycaprolactone based parenteral formulation of aripiprazole targeting behavioral and biochemical deficit in schizophrenia" @default.
- Q104684902 P2093 "Lavjot Kaur" @default.
- Q104684902 P2093 "V R Sinha" @default.
- Q104684902 P31 Q13442814 @default.
- Q104684902 P356 "10.1016/J.XPHS.2020.12.028" @default.
- Q104684902 P577 "2020-12-28T00:00:00Z" @default.
- Q104684902 P698 "33383057" @default.
- Q104684902 P921 Q41112 @default.